Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects

NCT00908271 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT00908271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00908271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Absolute Oral Bioavailability of Dapagliflozin in Healthy Subjects
Lead sponsor
AstraZeneca
Phase
Phase 1
Overall status
Completed
Start date
July 31, 2009
Completion date
August 31, 2009
Enrollment
7 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type 2 diabetes mellitus